SCRC Faculty in COVID-19 News
SCRC Faculty in the News on the COVID-19 Pandemic
Aug 19, 2020 - SCRC
Portable imager could massively increase testing across nation by end of 2020
July 13, 2020 - SCRC
UCI scientists found a way to synthesize the depleting sample-preserving fluid, a critical ingredient of COVID-19 test kits, in campus laboratories, called viral transport medium.
July 1, 2020 - SCRC
"This partnership between Nanommune and Velox can make an immediate impact in the fight against the ongoing COVID-19 outbreak," said Dr. Byron Shen, CEO of Velox Biosystems, Inc.
May 2020 - SCRC
If SARS-CoV2 is able to enter the CNS, it will be imperative to design effective anti-viral drugs that can enter the CNS to dampen viral replication and spread throughout the brain.
Accelerating pipelines toward COVID-19 therapies and vaccines using high-throughput single-cell functional screening
May 2020 - SCRC
To develop a platform technology that can accelerate development of prophylactic and treatment vaccines and antivirus therapeutic antibodies against COVID-19.
April 24, 2020 - CIRM Blog
This marks CIRM’s first clinical study for COVID-19 after approving emergency funding a month earlier.
April 15, 2020
Michele Bratcher Goodwin, Chancellors Professor of Law and SCRC faculty on stem cell ethics, publishes on the threat of the pandemic to voting rights.
April 10, 2020 - CIRM Blog
SCRC faculty and Samueli School engineers are answering the call for simple and affordable ventilators, using off-the-shelf parts to meet the unprecedented demand.
April 7, 2020 - UCI News
“We set up a mini task force of related medical investigators and faculty from various schools,” says Aileen Anderson, professor and director of the Sue & Bill Gross Stem Cell Research Center.
March 30, 2020 - Ms. Magazine
Michele Goodwin, SCRC faculty and a law professor at the University of California, Irvine, said questions about civil liberties are also being raised by the pandemic.
March 25, 2020 - Ms. Magazine
Michele Goodwin, SCRC faculty, writes about how racializing COVID-19 or any other disease harms society and serves no legitimate governmental or public policy purpose.
March 17, 2020 - WhoWhatWhy
There are concerns about the influence of “political expediency” on the independence of judges, and whether they can be counted on to rely “on the evidence at hand,” Michele Goodwin said.
March 6, 2020 - ACS Blog
Michele Goodwin, Chancellor’s Professor of Law and Director of the Center for Biotechnology and Global Health Policy, SCRC faculty on panel to speak to government authority during the health crisis.
Updates on projects supported by the flow core at the UCI Stem Cell Research Center.